Literature DB >> 5807477

Fluorometric determination of serum levels and urinary excretion of daunomycin (NSC-82151) in mice and rats.

J M Finkel, K T Knapp, L T Mulligan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5807477

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  8 in total

1.  Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin.

Authors:  R Supino; M Mariani; E Prosperi; G Parmiani
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Distribution and antitumoral activity of adriamycin combined with warfarin in mice.

Authors:  P Ghersa; M G Donelli
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Influence of tumor on adriamycin concentration in blood cells.

Authors:  M Broggini; T Colombo; S Garattini; M G Donelli
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.

Authors:  M A Alaoui Jamali; M B Yin; A Mazzoni; I Bankusli; Y M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.

Authors:  F Formelli; A M Casazza; A Di Marco; A Mariani; C Pollini
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Differential adriamycin distribution to blood components.

Authors:  T Colombo; M Broggini; S Garattini; M G Donelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

7.  Disposition and metabolism of [14-14C] 4-demethoxydaunorubicin HCl (idarubicin) and [14-14C]daunorubicin HCl in the rat. A comparative study.

Authors:  G Zini; G P Vicario; M Lazzati; F Arcamone
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Heparin does not modify plasma daunomycin disappearance in acute leukaemia patients.

Authors:  E Piazza; S Cortellazzo; L Ottolenghi; A Poggi; T Barbui; M B Donati
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.